Iinkcukacha ezithe xaxe ― Isixhosa

Urticaria idla ngokurhawuzelelwa ngokunyuka kwe welts. Ngamanye amaxesha ihamba kunye nokuvuvukala kwezicubu eziphantsi. Unyango ikakhulu lubandakanya ukuphepha izinto ezibangela ukuba zikwazi, ukuba ziyaziwa. Amayeza odidi lokuqala aquka ii-antihistamines ezintsha, ezinokuthi zilungelelaniswe kwiidosi eziphezulu ukuba ziyafuneka. Amanye amayeza afana ne-antihistamines endala, i-H2 blockers, i-leukotriene receptor antagonists, i-antihistamine enamandla, kunye nezifundo ezimfutshane ze-corticosteroids zingongezwa njengenkxaso eyongezelelweyo. Kwiimeko apho i-urticaria ithe gqolo ngaphandle kwala manyathelo, izigulane zinokuthunyelwa kwiingcaphephe kunyango olongezelelweyo olunje nge omalizumab okanye cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Olu phononongo luchaza izikhokelo zamva nje zonyango lwe-urticaria kwaye lunikeza ukuqonda okutsha kwezizathu zayo.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids